Cohen & Steers Global Income Builder, Inc. (INB) financial statements (2021 and earlier)

Company profile

Business Address 225 LONG AVENUE
HILLSIDE, NJ 07205
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000000
Cash and cash equivalents0000000
Restricted cash and investments    011
Receivables5644433
Inventory, net of allowances, customer advances and progress billings141098886
Inventory141098886
Other current assets1000000
Total current assets:1916141213129
Noncurrent Assets
Operating lease, right-of-use asset33
Property, plant and equipment2222221
Intangible assets, net (including goodwill)     01
Intangible assets, net (excluding goodwill)     01
Deposits noncurrent assets0000000
Deferred income tax assets22
Deferred tax assets, net111  
Other undisclosed noncurrent assets  3    
Total noncurrent assets:6662322
TOTAL ASSETS:25232015151412
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6444455
Accounts payable6444455
Debt3311111
Due to related parties  05000
Other undisclosed current liabilities5676656
Total current liabilities:14131216111212
Noncurrent Liabilities
Long-term debt and lease obligation3434454
Long-term debt, excluding current maturities0134454
Operating lease, liability22
Liabilities, other than long-term debt    655
Due to related parties    555
Derivative instruments and hedges, liabilities    100
Other undisclosed noncurrent liabilities(2)(2)3    
Total noncurrent liabilities:346410119
Total liabilities:17171820212221
Stockholders' equity
Stockholders' equity attributable to parent862(5)(6)(8)(9)
Common stock0000000
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital50505045454545
Accumulated deficit(42)(44)(48)(50)(51)(53)(54)
Total stockholders' equity:862(5)(6)(8)(9)
TOTAL LIABILITIES AND EQUITY:25232015151412

Income statement (P&L) ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Revenues57535044474237
Revenue, net 474237
Cost of revenue
(Cost of Goods and Services Sold)
(49)(46)(44)(39)(40)(37)(33)
Other undisclosed gross profit      0
Gross profit:8765764
Operating expenses(4)(3)(4)(3)(3)(3)(4)
Other undisclosed operating income      1
Operating income:4332321
Nonoperating expense(0)(0)(1)(1)(1)(1)(0)
Other nonoperating income (expense)00(0)0000
Interest and debt expense(0)(0)(1)(1)(1)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes0011111
Income from continuing operations before income taxes:4321211
Income tax expense (benefit)11(0)(0)0(0)(0)
Net income available to common stockholders, basic:5421211
Interest on convertible debt   00 0
Dilutive securities, effect on basic earnings per share   (0)0 (1)
Net income available to common stockholders, diluted:5420310

Comprehensive Income ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Net income:5421211
Comprehensive income, net of tax, attributable to parent:5421211

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: